Pharmacotherapeutic Management of Trigeminal Neuropathic Pain: An Update

Joseph V. Pergolizzi, Christopher Gharibo, Peter Magnusson, Frank Breve, Jo Ann LeQuang & Giustino Varrassi 
(2022) Pharmacotherapeutic Management of Trigeminal Neuropathic Pain: An Update, Expert Opinion on Pharmacotherapy
DOI: 10.1080/14656566.2022.2087507

Introduction: Guidelines recommend a number of pharmacotherapeutic options used as monotherapy or in combination with others for treating the pain of trigeminal neuropathy. Areas covered: The authors examine the pharmacotherapeutic options for treating trigeminal neuralgia and supporting evidence in the literature. Guidelines reported the most effective treatment for trigeminal neuropathy, in particular trigeminal neuralgia, appears to be carbamazepine or oxcabazepine, but side effects can be treatment limiting. Lamogitrine and gabapentin are also recommended in guidance. In real-world clinical practice, baclofen, cannabinoids, eslicarbazepine, levetiracetam, brivaracetam, lidocaine, misoprostol, opioids, phenytoin, fosphenytoin, pimozide, sodium valproate, sumatriptan, tizanidine, tocainide, tricyclic antidepressants, and vixotrigine are sometimes used, either as monotherapy or in combination. The relatively small patient population has limited the number of large-scale studies and there is limited evidence on which to base prescribing choices. Expert opinion: While there is no optimal pharmacotherapy for treating trigeminal neuropathy, advancements in our understanding of the underlying mechanisms of this condition and drug development indicate promise for NaV inhibitors, despite the fact that not all patients respond to them and they may have potentially treatment-limiting side effects. Nevertheless, better understanding of NaV channels may be important avenues for future drug development for trigeminal neuropathy.

Associazione Italiana per lo Studio del Dolore
Email: -
Sede legale: Via Tacito 7 - 00193 Roma

Articoli, notizie, comunicati possono essere inviati a:


L'Associazione Italiana per lo Studio del Dolore è il capitolo italiano dell'International Association for the Study of Pain IASP® e della European Pain Federation EFIC®